Soleno Therapeutics, Inc. (SLNO)
52.94
0.00 (0.00%)
USD |
NASDAQ |
May 07, 14:11
Soleno Therapeutics SG&A Expense (TTM) : 132.13M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Neurocrine Biosciences, Inc. | 879.70M |
| Nektar Therapeutics | 68.67M |
| Forian, Inc. | 15.44M |
| Boston Scientific Corp. | 7.072B |
| Integer Holdings Corp. | 219.30M |